Literature DB >> 3000665

Study of activated T cells in man. II. Interleukin 2 receptor and transferrin receptor expression on T cells and production of interleukin 2 in patients with acquired immune deficiency syndrome (AIDS) and AIDS-related complex.

S Gupta.   

Abstract

Because the expression of interleukin 2 (IL-2) receptor and transferrin receptor is essential for the proliferation of T cells to mitogens and antigens, we examined the expression of monoclonal antibody defined IL-2 receptor (Tac antigen) and transferrin receptor on unstimulated as well as on phytohemagglutinin (PHA)-activated highly enriched T cells from patients with acquired immune deficiency syndrome (AIDS) and AIDS-related complex (ARC). A trend of increased proportion of unstimulated T cells with Tac antigen and transferrin receptor was observed in patients with AIDS and ARC when compared to healthy heterosexual controls, but the differences were not significantly (P greater than 0.1). The proportions of Tac+ PHA-activated T cells were, however, significantly decreased in AIDS (P less than 0.001). ARC (P less than 0.001), and asymptomatic homosexuals (P less than 0.01) when compared to healthy heterosexuals. The proportions of transferrin receptor positive PHA-activated T cells were not significantly different among various groups. A significantly (P less than 0.01) decreased production of IL-2 was observed in AIDS. This study suggests that the poor proliferative responses of T cells may be due to several defects in lymphocyte-cytokine cascade and the deficiency of Tac antigen expression and of the production of IL-2 could be a few of several abnormalities contributing to poor T-cell functions in AIDS.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3000665     DOI: 10.1016/0090-1229(86)90126-1

Source DB:  PubMed          Journal:  Clin Immunol Immunopathol        ISSN: 0090-1229


  15 in total

1.  Treatment of the acquired immune deficiency syndrome.

Authors:  S Gupta; M S Gottlieb
Journal:  J Clin Immunol       Date:  1986-05       Impact factor: 8.317

2.  Preferential loss of Leu 8-, CD45R, HLA-DR+ CD8 cell subsets during in vitro culture of mononuclear cells from human immunodeficiency virus type I (HIV)-seropositive former blood donors.

Authors:  H E Prince; C D Czaplicki
Journal:  J Clin Immunol       Date:  1989-09       Impact factor: 8.317

3.  Impairment in T-lymphocyte responses during early infection with the human immunodeficiency virus.

Authors:  J Bentin; C D Tsoukas; J A McCutchan; S A Spector; D D Richman; J H Vaughan
Journal:  J Clin Immunol       Date:  1989-03       Impact factor: 8.317

4.  In vitro activation of T lymphocytes from human immunodeficiency virus (HIV)-seropositive blood donors. I. Soluble interleukin 2 receptor (IL2R) production parallels cellular IL2R expression and DNA synthesis.

Authors:  H E Prince; S H Kleinman; V C Maino; A L Jackson
Journal:  J Clin Immunol       Date:  1988-03       Impact factor: 8.317

5.  Lymphocyte transformation induced by autologous cells: XVIII. Impaired autologous mixed lymphocyte reaction in subjects with AIDS-related complex.

Authors:  F C Garbrecht; G W Siskind; M E Weksler
Journal:  Clin Exp Immunol       Date:  1987-02       Impact factor: 4.330

Review 6.  Cellular immunology of HIV-infection.

Authors:  G P Spickett; A G Dalgleish
Journal:  Clin Exp Immunol       Date:  1988-01       Impact factor: 4.330

7.  Humoral-mediated suppression of interleukin 2-dependent target cell proliferation in acquired immune deficiency syndrome (AIDS): interference with normal IL-2 receptor expression.

Authors:  R P Donnelly; M F La Via; K Y Tsang
Journal:  Clin Exp Immunol       Date:  1987-06       Impact factor: 4.330

8.  Immunophenotypical alterations in a subset of patients with common variable immunodeficiency (CVID).

Authors:  E Baumert; G Wolff-Vorbeck; M Schlesier; H H Peter
Journal:  Clin Exp Immunol       Date:  1992-10       Impact factor: 4.330

9.  Heterogeneous effects of exogenous IL-2 on HIV-specific cell-mediated immunity (CMI).

Authors:  S J Bell; D A Cooper; B E Kemp; R R Doherty; R Penny
Journal:  Clin Exp Immunol       Date:  1992-10       Impact factor: 4.330

10.  The significance of serum soluble IL-2 receptor as a marker for active visceral leishmaniasis in Sicilian patients.

Authors:  G Vitale; G Reina; S Mansueto; R Malta; G Gambino; C Mocciaro; R D'Agostino; M Dieli; E Cillari
Journal:  Clin Exp Immunol       Date:  1992-11       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.